LATEST NEWS
EXACT Therapeutics and Cordance Medical Announce Early Encouraging Data in Brain Cancer Mice Model
EXACT Therapeutics Announces FDA Clearance of IND for ENACT, a Phase 2 Trial in Pancreatic Cancer
EXACT Therapeutics Receives Investment from GE HealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer using ACT®

EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenus Inc.
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer